Cabazitaxel +/- Carboplatin vs 177Lu-PSMA-617 in Metastatic Castrate-resistant Prostate Cancer

Clinical trial NCT06738303 · RECRUITING

Trial details

NCT number: NCT06738303
Sponsor: Case Comprehensive Cancer Center
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Prostate Cancer Metastatic Castration-resistant Prostate Cancer

Start date: 2025-07-14
Primary completion: 2026-12-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.